Cancer, Advanced Completed Phase 1 Trials for Anlotinib (DB11885)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02825563A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer PatientsTreatment
NCT01833923A Phase I Study of Anlotinib on Tolerance and PharmacokineticsTreatment